Alphatec Holdings (ATEC) Income from Continuing Operations (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Income from Continuing Operations came in at -$25.8 million in Q2 2026, up 37.34% year-over-year from -$18.8 million in Q2 2025, and up 23.96% quarter-over-quarter from -$33.9 million in Q1 2026.
Analysis
Alphatec Holdings (ATEC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Income from Continuing Operations across 17 years of filings, most recently posting -$25.8 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 37.34% year-over-year to -$25.8 million; the TTM figure through Jun 2026 stood at -$79.9 million (up 52.02% YoY), while the FY2025 annual figure was -$113.3 million, up 30.37% from the prior year.
- Income from Continuing Operations came in at -$25.8 million for Q2 2026 at Alphatec Holdings, up from -$33.9 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of $8.3 million in Q4 2025 to a low of -$51.9 million in Q1 2025.
- Average Income from Continuing Operations over 5 years is -$37.5 million, with a median of -$40.1 million recorded in 2024.
- Year-over-year, Income from Continuing Operations plunged 86.07% in 2022 and jumped 124.59% in 2025.
- Over 5 years, Income from Continuing Operations stood at -$34.8 million in 2022, then plunged by 43.48% to -$49.9 million in 2023, then jumped by 32.04% to -$33.9 million in 2024, then jumped by 124.59% to $8.3 million in 2025, then slumped by 409.09% to -$25.8 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$25.8 million in Q2 2026, -$33.9 million in Q1 2026, and $8.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Alphatec Holdings | 1.38 Bn | 1.26 Bn | 154.10 Mn | -25.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.78 Mn |
| Mar 31, 2026 | -33.91 Mn |
| Dec 31, 2025 | 8.34 Mn |
| Sep 30, 2025 | -28.58 Mn |
| Jun 30, 2025 | -41.14 Mn |
| Mar 31, 2025 | -51.91 Mn |
| Dec 31, 2024 | -33.92 Mn |
| Sep 30, 2024 | -39.62 Mn |
| Jun 30, 2024 | -40.68 Mn |
| Mar 31, 2024 | -48.50 Mn |
| Dec 31, 2023 | -49.91 Mn |
| Sep 30, 2023 | -42.65 Mn |
| Jun 30, 2023 | -51.38 Mn |
| Mar 31, 2023 | -43.53 Mn |
| Dec 31, 2022 | -34.78 Mn |
| Sep 30, 2022 | -36.79 Mn |
| Jun 30, 2022 | -37.10 Mn |
| Mar 31, 2022 | -42.62 Mn |
| Dec 31, 2021 | -38.89 Mn |
| Sep 30, 2021 | -43.03 Mn |